Literature DB >> 7638934

Control of bovine tuberculosis by vaccination.

D G Newell1, R G Hewinson.   

Abstract

The control of bovine tuberculosis remains a significant problem in the United Kingdom, especially in the south west of England where the rising prevalence of the disease is attributed to a reservoir of Mycobacterium bovis infection in badgers. The possibility of controlling the disease by the vaccination of cattle has been unpopular with veterinarians largely because of the potential compromise of existing diagnostic tests. However, the vaccination of badgers to reduce the risk of transmission to cattle is an attractive option and has now been adopted as a potential control strategy. Recent research has led to important advances in the molecular genetics of mycobacteria and in the understanding of protective immune responses. These advances mean that it may be feasible to design and develop effective mycobacterial vaccines. This review summarises the current understanding of protective immunity against M bovis infection and discusses the possible strategies for the development of vaccines.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7638934     DOI: 10.1136/vr.136.18.459

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  3 in total

1.  Vaccination of guinea pigs with nutritionally impaired avirulent mutants of Mycobacterium bovis protects against tuberculosis.

Authors:  G W De Lisle; T Wilson; D M Collins; B M Buddle
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  A model of bovine tuberculosis control in domesticated cattle herds.

Authors:  R R Kao; M G Roberts; T J Ryan
Journal:  Proc Biol Sci       Date:  1997-07-22       Impact factor: 5.349

3.  Generation of CD8(+) T-cell responses to Mycobacterium bovis and mycobacterial antigen in experimental bovine tuberculosis.

Authors:  E Liébana; R M Girvin; M Welsh; S D Neill; J M Pollock
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.